Should denosumab treatment for osteoporosis be continued indefinitely?

Ther Adv Endocrinol Metab · 2021 · PMC8072936 · PMID 34104392

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Numerically, more participants in the denosumab arm experienced serious adverse events of infections involving the gastrointestinal system, renal and urinary system, ear and endocarditis – but these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.